We previously observed that treatment with Met for a short period of approximately 6 h conferred a better migration or expansion ability, or both, on tumor-specific, naive CD8+ T cells in the tumor after their adoptive transfer to tumor-bearing mice, compared with those of the CD8+ T cells without Met treatment. Here, CD8A is linked to neoplasm.